159 related articles for article (PubMed ID: 7600744)
1. Is ACE inhibition with lisinopril helpful in diabetic neuropathy?
Reja A; Tesfaye S; Harris ND; Ward JD
Diabet Med; 1995 Apr; 12(4):307-9. PubMed ID: 7600744
[TBL] [Abstract][Full Text] [Related]
2. Ranirestat for the management of diabetic sensorimotor polyneuropathy.
Bril V; Hirose T; Tomioka S; Buchanan R;
Diabetes Care; 2009 Jul; 32(7):1256-60. PubMed ID: 19366965
[TBL] [Abstract][Full Text] [Related]
3. Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril.
Cameron NE; Cotter MA; Robertson S
Acta Diabetol; 1993; 30(1):46-8. PubMed ID: 8392403
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.
Bril V; Buchanan RA
Diabetes Care; 2006 Jan; 29(1):68-72. PubMed ID: 16373898
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration.
Nicolucci A; Carinci F; Cavaliere D; Scorpiglione N; Belfiglio M; Labbrozzi D; Mari E; Benedetti MM; Tognoni G; Liberati A
Diabet Med; 1996 Dec; 13(12):1017-26. PubMed ID: 8973882
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial.
Malik RA; Williamson S; Abbott C; Carrington AL; Iqbal J; Schady W; Boulton AJ
Lancet; 1998 Dec 19-26; 352(9145):1978-81. PubMed ID: 9872248
[TBL] [Abstract][Full Text] [Related]
7. Relationship between electroneurographic changes and serum ubiquitin levels in patients with type 2 diabetes.
Akarsu E; Pirim I; Capoğlu I; Deniz O; Akçay G; Unüvar N
Diabetes Care; 2001 Jan; 24(1):100-3. PubMed ID: 11194212
[TBL] [Abstract][Full Text] [Related]
8. Peripheral nerve function is increasingly impaired during puberty in adolescents with type 1 diabetes.
Riihimaa PH; Suominen K; Tolonen U; Jäntti V; Knip M; Tapanainen P
Diabetes Care; 2001 Jun; 24(6):1087-92. PubMed ID: 11375375
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy.
Valensi P; Attali JR; Gagant S
Diabet Med; 1993 Dec; 10(10):933-9. PubMed ID: 8306589
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.
Tkac I; Bril V
Diabetes Care; 1998 Oct; 21(10):1749-52. PubMed ID: 9773742
[TBL] [Abstract][Full Text] [Related]
11. Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial.
Chuar PF; Ng YT; Phang SCW; Koay YY; Ho JI; Ho LS; Botross Henien NP; Ahmad B; Abdul Kadir K
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836025
[TBL] [Abstract][Full Text] [Related]
12. Subclinical nerve dysfunction in children and adolescents with IDDM.
Hyllienmark L; Brismar T; Ludvigsson J
Diabetologia; 1995 Jun; 38(6):685-92. PubMed ID: 7672490
[TBL] [Abstract][Full Text] [Related]
13. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy.
Veves A; Malik RA; Lye RH; Masson EA; Sharma AK; Schady W; Boulton AJ
Diabet Med; 1991 Dec; 8(10):917-21. PubMed ID: 1838042
[TBL] [Abstract][Full Text] [Related]
14. Topiramate and physiologic measures of nerve function in polyneuropathy.
Freeman R; McIntosh KA; Vijapurkar U; Thienel U
Acta Neurol Scand; 2007 Apr; 115(4):222-31. PubMed ID: 17376119
[TBL] [Abstract][Full Text] [Related]
15. Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function.
Plater ME; Ford I; Dent MT; Preston FE; Ward JD
Diabetologia; 1996 Mar; 39(3):336-43. PubMed ID: 8721780
[TBL] [Abstract][Full Text] [Related]
16. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
Jamal GA; Carmichael H
Diabet Med; 1990 May; 7(4):319-23. PubMed ID: 2159860
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients.
Ziegler D; Dannehl K; Wiefels K; Gries FA
Diabet Med; 1992; 9(7):622-9. PubMed ID: 1511568
[TBL] [Abstract][Full Text] [Related]
18. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
Karsidag S; Morali S; Sargin M; Salman S; Karsidag K; Us O
Diabetes Res Clin Pract; 2005 Mar; 67(3):211-9. PubMed ID: 15713353
[TBL] [Abstract][Full Text] [Related]
19. Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes.
Jarmuzewska EA; Mangoni AA
J Intern Med; 2005 Jul; 258(1):38-44. PubMed ID: 15953131
[TBL] [Abstract][Full Text] [Related]
20. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
Han LP; Yu DM; Xie Y
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2513-5. PubMed ID: 19080636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
